Clinical Trial Update: The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine [NA]

View source ↗

Summary

Clinical trial investigating the impact of triptan and doxycycline on neuroinflammatory biomarkers in acute migraine has been withdrawn. Sponsor: The Cleveland …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Doxycycline (Doxycycline)
• Triptan (triptan)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Migraine Disorders, Headache, Migraine | NA | Status: WITHDRAWN